Market Movers

Walgreens Boots Alliance, Inc.’s Stock Price Plummets to $16.68, Marking a Significant 6.40% Drop

Walgreens Boots Alliance, Inc. (WBA)

16.68 USD -1.14 (-6.40%) Volume: 25.03M

Walgreens Boots Alliance, Inc.’s stock price stands at 16.68 USD, experiencing a significant drop of -6.40% in the latest trading session with a high trading volume of 25.03M, reflecting a challenging year with a year-to-date percentage change of -36.12%.


Latest developments on Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance (WBA) stock price has been experiencing fluctuations recently, amidst news of major events within the company. Quadrant Capital Group LLC recently purchased shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA), while Principal Financial Group Inc. sold off a significant number of shares. Additionally, Walgreens Boots Alliance is seeking a Β£7 billion sale, leading investors to speculate on the future of the company. With questions surrounding when Walgreens stock will rise again and the stock being labeled as a trending stock, it is clear that there is a lot of interest and activity surrounding Walgreens Boots Alliance in the market today.


Walgreens Boots Alliance, Inc. on Smartkarma

Analysts on Smartkarma are closely monitoring Walgreens Boots Alliance, with reports from providers like Baptista Research and Travis Lundy offering valuable insights. Baptista Research‘s analysis focuses on the company’s recent earnings, highlighting an adjusted EPS of $1.20 and solid performance in both the U.S. Retail Pharmacy segment and internationally. The report also delves into factors that could influence the company’s stock price in the near future, utilizing a Discounted Cash Flow methodology for valuation.

Meanwhile, Travis Lundy’s report discusses Walgreens’ removal from the Dow Jones Industrial Average and the historical performance of companies in similar situations. With Walgreens being cheaper than CVS and recent changes in the index, including Amazon replacing Walgreens, Lundy provides a unique perspective on the company’s position in the market.


A look at Walgreens Boots Alliance, Inc. Smart Scores

FactorScoreMagnitude
Value4
Dividend5
Growth2
Resilience2
Momentum3
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

According to the Smartkarma Smart Scores, Walgreens Boots Alliance has a strong outlook for its dividend and value factors, scoring a 5 and 4 respectively. This indicates that the company is performing well in terms of providing returns to its shareholders and being undervalued compared to its competitors. However, the growth and resilience scores are lower at 2, suggesting that there may be challenges in these areas for the company in the long term. The momentum score of 3 indicates a moderate level of positive movement for Walgreens Boots Alliance.

Walgreens Boots Alliance, Inc., a retail drugstore operator, seems to have a solid foundation in terms of its dividend and value offerings. With a focus on providing a wide range of prescription and non-prescription drugs, as well as health services such as primary and acute care, the company is positioned well to meet the needs of its customers. While there may be room for improvement in terms of growth and resilience, the company’s overall outlook remains positive, especially with its strong emphasis on dividends and value for investors.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars